Kräker, Kristin
Herse, Florian
Golic, Michaela
Reichhart, Nadine
Crespo-Garcia, Sergio
Strauß, Olaf
Grune, Jana
Kintscher, Ulrich
Ebrahim, Manal
Bader, Michael
Alenina, Natalia
Heuser, Arnd
Luft, Friedrich C.
Müller, Dominik N.
Dechend, Ralf
Haase, Nadine
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
Projekt DEAL
Article History
Received: 14 February 2020
Accepted: 23 June 2020
First Online: 20 August 2020
Competing interests
: RD has have served as advisor for Boehringer Ingelheim and has lectured on empaglifozin. UK took part on an Advisory Board from Boehringer Ingelheim. The rest of the authors have no competing interests.